Showing results (111-120 of 286) with videos related to

Sort By:
Pageof 29
Diabetic Medicine : a Journal of the British Diabetic Association|January 26, 2006
Identifying the impact of diabetes researchS R Hanney, P D Home, I Frame, et al.
Diabetologia|November 1, 1981
The influence of glucose-induced hyperinsulinaemia on renal glomerular function and circulating catecholamines in normal manG C Viberti, C R Strakosch, H Keen, et al.
Diabetes & Metabolism|June 18, 2017
Glycaemic control and hypoglycaemia with insulin glargine 300U/mL versus insulin glargine 100U/mL in insulin-naïve people with type 2 diabetes: 12-month results from the EDITION 3 trialG B Bolli, M C Riddle, R M Bergenstal, et al.
Clinical Science (London, England : 1979)|April 1, 1990
Total-body potassium in insulin-dependent diabetes mellitusT H Goodship, P C Butler, D Rodham, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 1, 1985
Prevalence of morning hyperglycaemia: determinants of fasting blood glucose concentrations in insulin-treated diabeticsA J Francis, P D Home, S Walford, et al.
European Journal of Pediatrics|April 1, 1986
Overnight metabolic profiles in very young insulin-dependent diabetic childrenC E de Beaufort, G J Bruining, P D Home, et al.
Diabetes, Obesity & Metabolism|November 20, 2014
Efficacy and tolerability of albiglutide versus placebo or pioglitazone over 1 year in people with type 2 diabetes currently taking metformin and glimepiride: HARMONY 5P D Home, P Shamanna, M Stewart, et al.
Diabetologia|December 1, 1983
Glycosylated haemoglobin in cord blood following normal and diabetic pregnanciesR Worth, L Ashworth, P D Home, et al.
Metabolism: Clinical and Experimental|May 1, 1981
Continuous subcutaneous insulin infusion: comparison of plasma insulin profiles after infusion or bolus injection of the mealtime doseP D Home, J C Pickup, H Keen, et al.
Diabetologia|June 10, 2010
Experience of malignancies with oral glucose-lowering drugs in the randomised controlled ADOPT (A Diabetes Outcome Progression Trial) and RECORD (Rosiglitazone Evaluated for Cardiovascular Outcomes and Regulation of Glycaemia in Diabetes) clinical trialsP D Home, S E Kahn, N P Jones, et al.
Pageof 29